Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Goose Capital
- Ownership
- Private
- Development stage
- Other
01
Overview
Blue Goose Capital invests in early-stage biopharma and medical device startups with a focus on US and Spain. Portfolio highlights include Mythic Therapeutics’ FateControl™ ADC platform ($103M Series B), Leuko’s noninvasive WBC monitor ($5M Series A), and Aluna’s respiratory health platform (~$19M raised). No direct clinical results as it does not develop drugs/devices itself.
- Therapeutic areas
- NeurologyOncologyOther
- Modalities
- Antibody-drug conjugateDeviceExoskeleton technology
- Industry
- Investors
02
Partnerships
MIT delta v acceleratorstrategic relocation agreements with offshore startups moving to US market
Beyond the preview
Go deeper on Blue Goose Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Blue Goose Capital.